Zobrazeno 1 - 10
of 58
pro vyhledávání: '"LEVENTE, BODOKI"'
Autor:
Enikő Sebestyén, Nóra Major, Levente Bodoki, Attila Makai, Ingrid Balogh, Gábor Tóth, Zsuzsanna Orosz, Péter Árkosy, Attila Vaskó, Katalin Hodosi, Zoltán Szekanecz, Éva Szekanecz
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesImmune checkpoint inhibitors (ICIs) stimulate antitumor immune responses and, in parallel, they might trigger autoimmune and other immunopathological mechanisms eventually leading to immune-related adverse events (irAE). In our study, we as
Externí odkaz:
https://doaj.org/article/9e98851974bb4c74bee94f1d85d3ec68
Autor:
Balázs Juhász, Katalin Gulyás, Ágnes Horváth, Edit Végh, Anita Pusztai, Ágnes Szentpétery, Zsófia Pethő, Nóra Bodnár, Attila Hamar, Levente Bodoki, Harjit Pal Bhattoa, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Szilvia Szamosi, Csaba Horváth, Sándor Szántó, Gabriella Szűcs, Hennie G. Raterman, Willem F. Lems, Oliver FitzGerald, Zoltán Szekanecz
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Introduction Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are associated with osteoporosis. There have not been many peripheral quantitative computed tomography (QCT) studies in patients receiving biologics. We assessed volumetr
Externí odkaz:
https://doaj.org/article/854910d3b56d4171a2efafc3c61464fd
Autor:
Anita Pusztai, Attila Hamar, Monika Czókolyová, Katalin Gulyás, Ágnes Horváth, Edit Végh, Zsófia Pethő, Szilvia Szamosi, Emese Balogh, Nóra Bodnár, Levente Bodoki, Ágnes Szentpétery, Harjit Pal Bhattoa, György Kerekes, Balázs Juhász, Éva Szekanecz, Katalin Hodosi, Andrea Domján, Sándor Szántó, Hennie G. Raterman, Willem F. Lems, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Cardiovascular (CV) disease and osteoporosis (OP) have been associated with rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Bone and vascular biomarkers and parameters along with the effect of 1-year anti-TNF therapy on these mark
Externí odkaz:
https://doaj.org/article/81ecefe24d80492490c1152dcc6c8038
Autor:
Levente, Bodoki, Andrea, Domján, Rebeka, Falcsik, Ágnes, Horváth, Zsófia, Pethô, Szilvia, Szamosi, Zoltán, Szekanecz, Gabriella, Szûcs, Dóra, Tari
Publikováno v:
Immunology Quarterly / Immunológiai Szemle; oct2024, Vol. 16 Issue 3, p95-107, 13p
Autor:
Zoltan Griger, Katalin Danko, Gabor Nemeth, Ziad Hassan, Zsuzsa Aszalos, Katalin Szabo, Levente Bodoki, Rudolf Gesztelyi, Judit Zsuga, Peter Szodoray, Adam Kemeny-Beke
Publikováno v:
International Journal of Ophthalmology, Vol 13, Iss 9, Pp 1443-1450 (2020)
AIM: To evaluate detailed anterior segment parameters of patients with idiopathic inflammatory myopathies (IIM), including polymyositis (PM), and dermatomyositis (DM), and to clarify the associations between these data and clinical variables of IIM.
Externí odkaz:
https://doaj.org/article/b6fc6baeb2ee41e3ad22664cfd532337
Autor:
Anett Vincze, Levente Bodoki, Katalin Szabó, Melinda Nagy-Vincze, Orsolya Szalmás, József Varga, Katalin Dankó, János Gaál, Zoltán Griger
Publikováno v:
BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract Background The prevalence of osteoporosis and risk of fractures is elevated in rheumatoid arthritis (RA), but we have limited information about the bone mineral density (BMD) and fracture risk in patients with inflammatory myopathies. We int
Externí odkaz:
https://doaj.org/article/3462f60c4b2f459aa90ef0cd9e4de1da
Autor:
Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Anita Szentpéteri, Ildikó Seres, Mariann Harangi, György Paragh, György Kerekes, Levente Bodoki, Andrea Domján, Katalin Hodosi, Tamás Seres, György Panyi, Zoltán Szekanecz, Gabriella Szűcs
Publikováno v:
Biomolecules, Vol 12, Iss 10, p 1483 (2022)
Background: Cardiovascular (CV) morbidity, mortality and metabolic syndrome are associated with rheumatoid arthritis (RA). A recent trial has suggested increased risk of major CV events (MACE) upon the Janus kinase (JAK) inhibitor tofacitinib compare
Externí odkaz:
https://doaj.org/article/1bf883c526d04d30b1814f3d8a0c694f
Autor:
Szűcs, Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Anita Szentpéteri, Ildikó Seres, Mariann Harangi, György Paragh, György Kerekes, Levente Bodoki, Andrea Domján, Katalin Hodosi, Tamás Seres, György Panyi, Zoltán Szekanecz, Gabriella
Publikováno v:
Biomolecules; Volume 12; Issue 10; Pages: 1483
Background: Cardiovascular (CV) morbidity, mortality and metabolic syndrome are associated with rheumatoid arthritis (RA). A recent trial has suggested increased risk of major CV events (MACE) upon the Janus kinase (JAK) inhibitor tofacitinib compare
Autor:
Sándor Mogyoróssy, Melinda Nagy-Vincze, Zoltán Griger, Katalin Dankó, Nóra Anna Szabó, Zoltán Szekanecz, Gabriella Szűcs, Antónia Szántó, Levente Bodoki
Publikováno v:
Autoimmunity Reviews. 22:103311
Autor:
Sándor Szántó, Yehuda Shoenfeld, Zoltán Prohászka, Katalin Hodosi, Eiji Matsuura, Levente Bodoki, Ágnes Horváth, Szilvia Szamosi, Edit Végh, Gábor Nagy, Nóra Bodnár, Zoltán Szekanecz, K. Gulyás, Ibolya Szöllősi, Gabriella Szűcs, Monika Czókolyová, Luis R. Lopez, György Kerekes, Andrea Domján, Zoltán Nagy, Attila Hamar, A. Pusztai
Publikováno v:
The Journal of Rheumatology. 48:821-828
Objective.Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) have been associated with cardiovascular disease. The treatment of arthritis by tumor necrosis factor-α (TNF-α) inhibitors may decrease the serum concentrations of vascular biomark